FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938657606> ?p ?o ?g. }

• W2938657606 endingPage "14" @default.
• W2938657606 startingPage "14" @default.
• W2938657606 abstract "We determine the prevalence of neutralizing antibodies (NAbs) to adeno-associated virus (AAV) in the vitreous humor and serum of patients with vitreoretinal diseases and investigate the relationship between NAb titers in the vitreous humor and serum.We analyzed NAbs to AAV serotypes 2, 5, 8, and 9 via in vitro neutralization in the vitreous humor and serum from 32 patients requiring vitrectomy for vitreoretinal diseases. The blood-retinal barrier (BRB) was evaluated for integrity based on preoperative examinations, with vitreous hemorrhage (VH) on funduscopy or dye leakage on fluorescein angiography observed indicating disruption.NAb levels were much lower in the vitreous humor than in the serum regardless of serotype. Patients with VH had higher levels of NAbs in the vitreous humor than those without VH. The NAb ratio (ratio between NAb titers in the serum and vitreous humor) was much lower in patients with epiretinal membrane with than in those without leakage. A significantly lower NAb ratio was noticed in patients with than in those without BRB disruptions.The NAb ratio between levels in serum and vitreous humor varies according to the condition of the BRB. Therefore, in addition to measuring the serum NAb level, physicians should examine BRB integrity when planning retinal gene therapy.This study provides substantial basis for retinal gene therapy using AAVs and how maintenance of BRB integrity in target diseases should be considered." @default.
• W2938657606 created "2019-04-25" @default.
• W2938657606 creator A5003819949 @default.
• W2938657606 creator A5006837277 @default.
• W2938657606 creator A5030958818 @default.
• W2938657606 creator A5035555889 @default.
• W2938657606 creator A5048382900 @default.
• W2938657606 creator A5066699499 @default.
• W2938657606 creator A5078144938 @default.
• W2938657606 creator A5089261967 @default.
• W2938657606 date "2019-04-09" @default.
• W2938657606 modified "2023-10-14" @default.
• W2938657606 title "Relationship Between Neutralizing Antibodies Against Adeno-Associated Virus in the Vitreous and Serum: Effects on Retinal Gene Therapy" @default.
• W2938657606 cites W1148361150 @default.
• W2938657606 cites W1531501691 @default.
• W2938657606 cites W168143921 @default.
• W2938657606 cites W1755815992 @default.
• W2938657606 cites W1993873224 @default.
• W2938657606 cites W1997582178 @default.
• W2938657606 cites W2053820810 @default.
• W2938657606 cites W2077204087 @default.
• W2938657606 cites W2080627917 @default.
• W2938657606 cites W2084654321 @default.
• W2938657606 cites W2096367348 @default.
• W2938657606 cites W2126115955 @default.
• W2938657606 cites W2137222303 @default.
• W2938657606 cites W2140722179 @default.
• W2938657606 cites W2142695353 @default.
• W2938657606 cites W2147346393 @default.
• W2938657606 cites W2473832992 @default.
• W2938657606 cites W2510758757 @default.
• W2938657606 cites W2554058929 @default.
• W2938657606 cites W2586306420 @default.
• W2938657606 cites W2615193664 @default.
• W2938657606 cites W265142245 @default.
• W2938657606 cites W2687813148 @default.
• W2938657606 cites W4211049074 @default.
• W2938657606 doi "https://doi.org/10.1167/tvst.8.2.14" @default.
• W2938657606 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6467092" @default.
• W2938657606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31016068" @default.
• W2938657606 hasPublicationYear "2019" @default.
• W2938657606 type Work @default.
• W2938657606 sameAs 2938657606 @default.
• W2938657606 citedByCount "16" @default.
• W2938657606 countsByYear W29386576062020 @default.
• W2938657606 countsByYear W29386576062021 @default.
• W2938657606 countsByYear W29386576062022 @default.
• W2938657606 countsByYear W29386576062023 @default.
• W2938657606 crossrefType "journal-article" @default.
• W2938657606 hasAuthorship W2938657606A5003819949 @default.
• W2938657606 hasAuthorship W2938657606A5006837277 @default.
• W2938657606 hasAuthorship W2938657606A5030958818 @default.
• W2938657606 hasAuthorship W2938657606A5035555889 @default.
• W2938657606 hasAuthorship W2938657606A5048382900 @default.
• W2938657606 hasAuthorship W2938657606A5066699499 @default.
• W2938657606 hasAuthorship W2938657606A5078144938 @default.
• W2938657606 hasAuthorship W2938657606A5089261967 @default.
• W2938657606 hasBestOaLocation W29386576061 @default.
• W2938657606 hasConcept C118487528 @default.
• W2938657606 hasConcept C134018914 @default.
• W2938657606 hasConcept C159654299 @default.
• W2938657606 hasConcept C203014093 @default.
• W2938657606 hasConcept C2777104736 @default.
• W2938657606 hasConcept C2778257484 @default.
• W2938657606 hasConcept C2778371105 @default.
• W2938657606 hasConcept C2779829184 @default.
• W2938657606 hasConcept C2780248432 @default.
• W2938657606 hasConcept C2780428090 @default.
• W2938657606 hasConcept C2780827179 @default.
• W2938657606 hasConcept C2781242345 @default.
• W2938657606 hasConcept C2781325737 @default.
• W2938657606 hasConcept C32611913 @default.
• W2938657606 hasConcept C555293320 @default.
• W2938657606 hasConcept C71924100 @default.
• W2938657606 hasConceptScore W2938657606C118487528 @default.
• W2938657606 hasConceptScore W2938657606C134018914 @default.
• W2938657606 hasConceptScore W2938657606C159654299 @default.
• W2938657606 hasConceptScore W2938657606C203014093 @default.
• W2938657606 hasConceptScore W2938657606C2777104736 @default.
• W2938657606 hasConceptScore W2938657606C2778257484 @default.
• W2938657606 hasConceptScore W2938657606C2778371105 @default.
• W2938657606 hasConceptScore W2938657606C2779829184 @default.
• W2938657606 hasConceptScore W2938657606C2780248432 @default.
• W2938657606 hasConceptScore W2938657606C2780428090 @default.
• W2938657606 hasConceptScore W2938657606C2780827179 @default.
• W2938657606 hasConceptScore W2938657606C2781242345 @default.
• W2938657606 hasConceptScore W2938657606C2781325737 @default.
• W2938657606 hasConceptScore W2938657606C32611913 @default.
• W2938657606 hasConceptScore W2938657606C555293320 @default.
• W2938657606 hasConceptScore W2938657606C71924100 @default.
• W2938657606 hasIssue "2" @default.
• W2938657606 hasLocation W29386576061 @default.
• W2938657606 hasLocation W29386576062 @default.
• W2938657606 hasLocation W29386576063 @default.
• W2938657606 hasLocation W29386576064 @default.
• W2938657606 hasOpenAccess W2938657606 @default.
• W2938657606 hasPrimaryLocation W29386576061 @default.
• W2938657606 hasRelatedWork W1986701879 @default.

• next